Literature DB >> 20094745

Usual suspects: anti-TNF drugs.

Ahmet Mesut Onat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20094745     DOI： 10.1007/s10067-009-1356-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  2 in total

1.  Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha.

Authors:  Osman Elbek; Meral Uyar; Neriman Aydin; Sermin Börekçi; Nazan Bayram; Hasan Bayram; Oner Dikensoy
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980

2.  An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.

Authors:  C P Denton; M Engelhart; N Tvede; H Wilson; K Khan; X Shiwen; P E Carreira; F Diaz Gonzalez; C M Black; F H van den Hoogen
Journal:  Ann Rheum Dis       Date:  2008-09-09       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.